MF59 is used in Europe as an adjuvant in influenza vaccines. In fact, owing to its ability to increase the levels of functional hemagglutination inhibiting antibodies and CD8 + T-cell responses ...

However, alternative approaches appear promising, including the use of MF59 adjuvant in combination with a lower antigen concentration, the use of new adjuvants, whole virus vaccines, cell culture ...